X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (837) 837
Publication (132) 132
Conference Proceeding (68) 68
Book Chapter (11) 11
Newsletter (2) 2
Book / eBook (1) 1
Book Review (1) 1
Magazine Article (1) 1
Poster (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (277) 277
male (212) 212
female (202) 202
middle aged (193) 193
hematology (171) 171
index medicus (164) 164
adult (163) 163
aged (147) 147
oncology (147) 147
antineoplastic combined chemotherapy protocols - therapeutic use (88) 88
transplantation (86) 86
treatment outcome (84) 84
chemotherapy (74) 74
computer science (65) 65
care and treatment (61) 61
prognosis (61) 61
lymphomas (57) 57
adolescent (56) 56
cancer (56) 56
rituximab (56) 56
immunology (54) 54
analysis (53) 53
retrospective studies (53) 53
lymphoma (52) 52
therapy (51) 51
life sciences (50) 50
disease-free survival (49) 49
networking and internet architecture (45) 45
telecommunications (44) 44
aged, 80 and over (43) 43
survival analysis (43) 43
disease (40) 40
survival (40) 40
stem cells (39) 39
non-hodgkins-lymphoma (37) 37
follow-up studies (36) 36
young adult (36) 36
[ info.info-ni ] computer science [cs]/networking and internet architecture [cs.ni] (34) 34
engineering, electrical & electronic (33) 33
survival rate (33) 33
trial (33) 33
computer science, information systems (32) 32
risk factors (32) 32
transplantation, homologous (32) 32
bone-marrow-transplantation (31) 31
recurrence (31) 31
wireless sensor networks (31) 31
leukemia (30) 30
transplantation, autologous (30) 30
remission induction (28) 28
stem-cell transplantation (28) 28
stem cell transplantation (27) 27
medicine, general & internal (26) 26
cyclophosphamide (25) 25
hematopoietic stem cell transplantation (25) 25
research (25) 25
acute myeloid-leukemia (24) 24
health aspects (24) 24
neoplasm staging (24) 24
diagnosis (23) 23
hematopoietic stem cell transplantation - methods (23) 23
hemic and lymphatic diseases (23) 23
antineoplastic agents - therapeutic use (22) 22
engineering (22) 22
hodgkin's disease (22) 22
patients (22) 22
performance analysis (22) 22
sensors (22) 22
wireless networks (22) 22
combined modality therapy (21) 21
hematology, oncology and palliative medicine (21) 21
prospective studies (21) 21
usage (21) 21
[sdv.can]life sciences [q-bio]/cancer (20) 20
computer science, hardware & architecture (20) 20
energy consumption (20) 20
lymphoma, follicular - drug therapy (20) 20
mechanics (20) 20
security (20) 20
studies (20) 20
transplantation conditioning - methods (20) 20
[ sdv.can ] life sciences [q-bio]/cancer (19) 19
abridged index medicus (19) 19
hodgkin disease - therapy (19) 19
mortality (19) 19
[info.info-ni]computer science [cs]/networking and internet architecture [cs.ni] (18) 18
antineoplastic combined chemotherapy protocols - administration & dosage (18) 18
child (18) 18
delay (18) 18
doxorubicin - therapeutic use (18) 18
high-dose therapy (18) 18
management (18) 18
mantle cell lymphoma (18) 18
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
cyclophosphamide - administration & dosage (17) 17
cyclophosphamide - therapeutic use (17) 17
drug therapy (17) 17
hematopoietic stem cells (17) 17
lymphoma, large b-cell, diffuse - drug therapy (17) 17
networks (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 06/2003, Volume 101, Issue 11, pp. 4279 - 4284
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4196 - 4196
Abstract Background: R/R DLBCL remains an area of unmet medical need and treatments with novel mechanisms of action are urgently needed. Germinal center DLBCLs... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5320 - 5320
Introduction: Targeting immune cells in the tumor microenvironment is an attractive approach to improving antitumor activity of standard therapy in r/r... 
Journal Article
Journal Article
Blood, ISSN 0006-4971, 01/2018, Volume 131, Issue 2, pp. 174 - 181
The benefit of radiotherapy (RT) following chemotherapy in limited-stage diffuse large B-cell lymphoma (DLBCL) remains controversial. Before the Rituximab (R)... 
Life Sciences | Hematology | Human health and pathology
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 248 - 248
Abstract Background Single-agent studies of lenalidomide in relapsed/refractory follicular lymphoma (FL) have demonstrated significant activity. Recent studies... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 393 - 393
Abstract The benefit of radiotherapy (RT) following chemotherapy in limited-stage DLBCL remains controversial. Before the Rituximab era, 4 randomized trials... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 146 - 146
Abstract The LyMa (ClinicalTrials.gov, NCT00921414) is a prospective randomised phase III trial conducted by the LYSA group (GOELAMS and GELA groups) and that... 
Journal Article
LANCET HAEMATOLOGY, ISSN 2352-3026, 01/2017, Volume 4, Issue 1, pp. E35 - E45
Background Radioimmunotherapy represents a potential option as consolidation after chemoimmunotherapy in patients with diffuse large B-cell lymphoma who are... 
RITUXIMAB-CHOP | THERAPY | OLDER PATIENTS | RESPONSE ASSESSMENT | CONSENSUS | NON-HODGKINS-LYMPHOMA | EPRATUZUMAB | TIUXETAN | RANDOMIZED CONTROLLED-TRIAL | HEMATOLOGY | CHEMOTHERAPY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.